Pharmacokinetics, pharmacodynamics, safety and tolerability of multiple ascending doses of ticagrelor in healthy volunteers-Reference-Cited by-同舟云学术

Pharmacokinetics, pharmacodynamics, safety and tolerability of multiple ascending doses of ticagrelor in healthy volunteers

Published:2010-03-22 Issue:1 Volume:70 Page:65-77
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Butler Kathleen,Teng Renli

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2125.2010.03669.x/fullpdf

Reference37 articles.

1. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Task force for diagnosis and treatment of non-ST-segment elevation acute coronary syndromes of the European Society of Cardiology;Bassand;Eur Heart J,2007

2. National Institute for Clinical Excellence (NICE) Post myocardial infarction secondary prevention in primary and secondary care for patients following a myocardial infarction: full guideline http://www.nice.org.uk/nicemedia/pdf/CG48FullGuideline.pdf

3. Durability of platelet inhibition by clopidogrel;Gurbel;Am J Cardiol,2003

4. Prevalence of clopidogrel non-responders among patients with stable angina pectoris scheduled for elective coronary stent placement;Müller;Thromb Haemost,2003

5. Variability in platelet responsiveness to clopidogrel among 544 individuals;Serebruany;J Am Coll Cardiol,2005

Cited by 134 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The SAFEST Study: Survey on Antiplatelets in Flow Diversion for Aneurysm Endovascular Treatment;Stroke: Vascular and Interventional Neurology;2024-09-06

2. Population pharmacokinetic study and application of ticagrelor and AR-C124910XX after percutaneous coronary intervention in Chinese patients with acute coronary syndrome;Int. Journal of Clinical Pharmacology and Therapeutics;2024-09-01

3. Role and recent progress of P2Y12 receptor in cancer development;Purinergic Signalling;2024-06-14

4. TICAGRELOR - MECHANISM OF ACTION AND ITS IMPACT ON DRUG EFFICACY;FARMACIA;2024

5. Five most important drug interactions in the critically ill;Anesteziologie a intenzivní medicína;2023-12-15